Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sung Bae Kim

Showing results (151-160 of 509) with videos related to

Pageof 51
Sort By:
Journal of Vascular and Interventional Radiology : JVIR|January 11, 2005
Comparison of temporary and permanent stent placement with concurrent radiation therapy in patients with esophageal carcinomaJi Hoon Shin, Ho-Young Song, Jong Hoon Kim, et al.
Breast Cancer Research and Treatment|April 26, 2008
Cost-effectiveness analysis of adjuvant therapy for node positive breast cancer in Korea: docetaxel, doxorubicin and cyclophosphamide (TAC) versus fluorouracil, doxorubicin and cyclophosphamide (FAC)Sang Gyu Lee, Young Geon Jee, Hyun Chul Chung, et al.
Head & Neck|December 22, 2016
Prevalence and clinical significance of cancer cachexia based on time from treatment in advanced-stage head and neck squamous cell carcinomaMinsu Kwon, Rock Bum Kim, Jong-Lyel Roh, et al.
BMC Cancer|July 31, 2012
Clinical outcomes of HER2-positive metastatic breast cancer patients with brain metastasis treated with lapatinib and capecitabine: an open-label expanded access study in KoreaJungsil Ro, Sohee Park, Sung- Bae Kim, et al.
The Lancet. Oncology|August 14, 2012
Subcutaneous versus intravenous administration of (neo)adjuvant trastuzumab in patients with HER2-positive, clinical stage I-III breast cancer (HannaH study): a phase 3, open-label, multicentre, randomised trialGustavo Ismael, Roberto Hegg, Susanne Muehlbauer, et al.
Korean Journal of Pathology|May 14, 2013
Human papillomavirus prevalence and cell cycle related protein expression in tonsillar squamous cell carcinomas of korean patients with clinicopathologic analysisMiji Lee, Sung Bae Kim, Sang-Wook Lee, et al.
Chembiochem : a European Journal of Chemical Biology|April 9, 2019
Near-Infrared Bioluminescence Imaging with a through-Bond Energy Transfer CassetteMasahiro Abe, Ryo Nishihara, Yuma Ikeda, et al.
International Journal of Experimental Pathology|June 10, 2016
Expression of FOXM1 and related proteins in breast cancer molecular subtypesJeong-Ju Lee, Hee Jin Lee, Byung-Ho Son, et al.
Molecules (Basel, Switzerland)|November 13, 2014
Curcumin reverse methicillin resistance in Staphylococcus aureusSu-Hyun Mun, Sung-Bae Kim, Ryong Kong, et al.
Breast (Edinburgh, Scotland)|September 3, 2010
Different prognostic significance of CD24 and CD44 expression in breast cancer according to hormone receptor statusHee Jeong Kim, Mi-Jung Kim, Sei Hyun Ahn, et al.
Pageof 51

Showing results (151-160 of 509) with videos related to

Sort By:
Pageof 51
Journal of Vascular and Interventional Radiology : JVIR|January 11, 2005
Comparison of temporary and permanent stent placement with concurrent radiation therapy in patients with esophageal carcinomaJi Hoon Shin, Ho-Young Song, Jong Hoon Kim, et al.
Breast Cancer Research and Treatment|April 26, 2008
Cost-effectiveness analysis of adjuvant therapy for node positive breast cancer in Korea: docetaxel, doxorubicin and cyclophosphamide (TAC) versus fluorouracil, doxorubicin and cyclophosphamide (FAC)Sang Gyu Lee, Young Geon Jee, Hyun Chul Chung, et al.
Head & Neck|December 22, 2016
Prevalence and clinical significance of cancer cachexia based on time from treatment in advanced-stage head and neck squamous cell carcinomaMinsu Kwon, Rock Bum Kim, Jong-Lyel Roh, et al.
BMC Cancer|July 31, 2012
Clinical outcomes of HER2-positive metastatic breast cancer patients with brain metastasis treated with lapatinib and capecitabine: an open-label expanded access study in KoreaJungsil Ro, Sohee Park, Sung- Bae Kim, et al.
The Lancet. Oncology|August 14, 2012
Subcutaneous versus intravenous administration of (neo)adjuvant trastuzumab in patients with HER2-positive, clinical stage I-III breast cancer (HannaH study): a phase 3, open-label, multicentre, randomised trialGustavo Ismael, Roberto Hegg, Susanne Muehlbauer, et al.
Korean Journal of Pathology|May 14, 2013
Human papillomavirus prevalence and cell cycle related protein expression in tonsillar squamous cell carcinomas of korean patients with clinicopathologic analysisMiji Lee, Sung Bae Kim, Sang-Wook Lee, et al.
Chembiochem : a European Journal of Chemical Biology|April 9, 2019
Near-Infrared Bioluminescence Imaging with a through-Bond Energy Transfer CassetteMasahiro Abe, Ryo Nishihara, Yuma Ikeda, et al.
International Journal of Experimental Pathology|June 10, 2016
Expression of FOXM1 and related proteins in breast cancer molecular subtypesJeong-Ju Lee, Hee Jin Lee, Byung-Ho Son, et al.
Molecules (Basel, Switzerland)|November 13, 2014
Curcumin reverse methicillin resistance in Staphylococcus aureusSu-Hyun Mun, Sung-Bae Kim, Ryong Kong, et al.
Breast (Edinburgh, Scotland)|September 3, 2010
Different prognostic significance of CD24 and CD44 expression in breast cancer according to hormone receptor statusHee Jeong Kim, Mi-Jung Kim, Sei Hyun Ahn, et al.
Pageof 51